Photonz fermentation product PNZ0901, is a drug substance comprising high purity eicosapentaenoic acid (EPA).
This product is produced using Photonz' proprietary algal fermentation technology which overcomes a number of obstacles previously encountered in continuous fermentation of microalgae.
Compared with existing methods of production the Photonz method has several significant advantages. It is; sustainable; secure; traceable; consistent; scaleable and animal-free.
Photonz owns or controls seven patent families covering fermentation and purification of microalgal EPA.